This inventor holds 1 USPTO granted patent. Top assignee: Chugai Seiyaku Kabushiki Kaisha. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Minoru Tamiya: Innovator in Selective KRAS Inhibition
Introduction
Minoru Tamiya is a notable inventor based in Kamakura, Japan. He has made significant contributions to the field of medicinal chemistry, particularly in the development of cyclic compounds with selective inhibitory effects on KRAS.
Latest Patents
Tamiya holds a patent for a cyclic compound that exhibits a selective KRAS inhibitory effect on HRAS and NRAS. This innovative compound has been found to interact with an amino acid residue specific to KRAS, showcasing its potential in targeted cancer therapies. The patent highlights the importance of selective inhibition in the treatment of diseases driven by these oncogenes.
Career Highlights
Throughout his career, Minoru Tamiya has been associated with Chugai Seiyaku Kabushiki Kaisha, a leading pharmaceutical company in Japan. His work has focused on the development of novel therapeutic agents that can effectively target specific pathways in cancer biology.
Collaborations
Tamiya has collaborated with esteemed colleagues, including Hatsuo Kawada and Koji Takano. Their combined expertise has contributed to advancements in the understanding and treatment of cancer.
Conclusion
Minoru Tamiya's innovative work in the field of selective KRAS inhibition represents a significant step forward in cancer research. His contributions continue to influence the development of targeted therapies that may improve patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile